Royalty Pharma Plc (RPRX)
52.85
-0.55
(-1.03%)
USD |
NASDAQ |
May 15, 16:00
52.86
+0.01
(+0.02%)
Pre-Market: 20:00
Royalty Pharma EPS Diluted (Quarterly) : 0.6738 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Zymeworks, Inc. | -0.592 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Elanco Animal Health, Inc. | 0.1126 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 468.26M |
| Revenue (Quarterly) | 630.58M |
| Total Expenses (Quarterly) | 335.89M |
| Enterprise Value | 34.82B |
| Gross Profit Margin (Quarterly) | 99.81% |
| Profit Margin (Quarterly) | 74.26% |
| Earnings Yield | 3.61% |
| Operating Earnings Yield | 5.95% |
| Normalized Earnings Yield | 3.623 |